Prospective observational multicenter study to evaluate the stability and quality of the visual function after the implantation of OptiBlue (ZCB00V) - Multicenter observational study of OptiBlue

Abbott Medical Optics Japan K.K.0 sites800 target enrollmentFebruary 1, 2013

Overview

Phase: 未知
Intervention: Not specified
Conditions: Patients implanted with ZCB00V for the improvement of visual acuity of aphakic eye
Sponsor: Abbott Medical Optics Japan K.K.
Enrollment: 800
Status: Recruiting
Last Updated: 2 years ago

No summary available.

Registry

who.int

Start Date

February 1, 2013

End Date

TBD

Last Updated

2 years ago

Study Type

Observational

Sex

All

Sponsor

Abbott Medical Optics Japan K.K.

•1\) Patients who have known systemic pathology, ophthalmologic disease or the history of previous surgery that may potentially affect visual functions 2\) Patients who have the history of previous corneal refractive surgery 3\) Patients who have been implanted with a multifocal intraocular lens or toric lens 4\) Patients who are taking or may take the medications that could potentially affect visual functions 5\) Patients with severe lens opacity 6\) Patients who have the abnormalities of lens capsule or zonule of Zinn due to the preoperative or intraoperative complications, and the abnormalities may potentially cause the incorrect positioning of the intraocular lens, which potentially affect visual functions 7\) Patients who have the pupillary abnormalities including no response, pupillotonia, shape anomaly or the condition mydriatic action (pupil diameter of 4 mm or longer) is not observed in the crepuscule or dark situation 8\) Patients who have an allergy to mydriatic agent 9\) Other patients considered unsuited for the study by the investigators